Shared Decision Making During Patient-Health Care Provider Encounters in Bipolar Depression Care

Overview

About this study

The purpose of this research is to understand the different ways in which patients and health care providers currently work together to figure out how to treat and manage bipolar depression. This process is called shared decision making. We aim to assess the characteristics and extent of shared decision making that has occurred during your clinical encounter.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

All participating health care providers will be provided with this list of inclusion and exclusion criteria to judge the eligibility of the patients for whom the study staff send in basket messages.

The inclusion criteria for the patients will be:

  • Age ≥ 18 years.
  • Clinical diagnosis of BD-I or BD-II.
  • Currently in a depressive episode as assessed by their psychiatric provider.
  • Patients with appointments scheduled at IBH and mood specialty clinics located at Mayo Clinic, Rochester, Minnesota.

The inclusion criteria for the health care providers will be:

  • All health care providers (e.g., consultants, advanced practice nurses, residents, or fellows in Psychiatry) willing to meet patients in designated IBH and mood specialty clinics

Exclusion Criteria: 

The patients with any of these conditions will be excluded from our study:

  • Having barriers to providing informed consent (e.g., dementia, severe hearing or visual impairment, severe psychosis)
  • Diagnosis of BD-SCZ.
  • Current mood state – manic/hypomanic, mixed, euthymic (as decided by the health care provider on the day of consultation)
  • Patients with severe suicidal ideation and plans and psychotic features lacking insight (as decided by the health care provider on the day of consultation)

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 4/14/2025. Questions regarding updates should be directed to the study team contact.
 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Mark Frye, M.D.

Open for enrollment

Contact information:

Karin Lindstrom Ph.D., M.A.

(507) 293-3876

Lindstrom.Karin@mayo.edu

More information

Publications

Publications are currently not available